-transparent.png){kind=logo}
In a continuing program to discover antipsychotic agents with a reduced propensity toward extrapyramidal side-effects, a series of N-alkoxyimides and -amides was prepared. Evaluation of these compounds in vitro revealed affinities for D2, 5HT2 and 5HT1A receptors. Several members of the series displayed a profile indicative of potential antipsychotic activity in preclinical assays. The most potent compound in these assays, 7, also displayed possible effectiveness for the negative symptoms of schizophrenia. The synthesis of these compounds and details of their structure-activity relationships are described.
Related Publications
N J Hrib, and
J G Jurcak, and
F P Huger, and
C L Errico, and
R W Dunn
September 2003,
Bioorganic & medicinal chemistry letters,
N J Hrib, and
J G Jurcak, and
F P Huger, and
C L Errico, and
R W Dunn
February 2018,
European journal of medicinal chemistry,
N J Hrib, and
J G Jurcak, and
F P Huger, and
C L Errico, and
R W Dunn
August 2016,
Bioorganic & medicinal chemistry letters,
N J Hrib, and
J G Jurcak, and
F P Huger, and
C L Errico, and
R W Dunn
January 2018,
Current computer-aided drug design,
N J Hrib, and
J G Jurcak, and
F P Huger, and
C L Errico, and
R W Dunn
March 2017,
Chemical biology & drug design,
N J Hrib, and
J G Jurcak, and
F P Huger, and
C L Errico, and
R W Dunn
March 2020,
Molecules (Basel, Switzerland),
N J Hrib, and
J G Jurcak, and
F P Huger, and
C L Errico, and
R W Dunn
October 2014,
Bioorganic & medicinal chemistry letters,
N J Hrib, and
J G Jurcak, and
F P Huger, and
C L Errico, and
R W Dunn
June 2009,
Journal of enzyme inhibition and medicinal chemistry,
N J Hrib, and
J G Jurcak, and
F P Huger, and
C L Errico, and
R W Dunn
January 2016,
Anti-inflammatory & anti-allergy agents in medicinal chemistry,
N J Hrib, and
J G Jurcak, and
F P Huger, and
C L Errico, and
R W Dunn
December 2020,
Archiv der Pharmazie,
